Fred Alger Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Hold |
2,433
| – | – | ﹤0.01% | 351 |
|
|
2025
Q4 | $1.1M | Sell |
2,433
-603
| -20% | -$260K | ﹤0.01% | 350 |
|
|
2025
Q3 | $1.19M | Sell |
3,036
-3,137
| -51% | -$1.31M | ﹤0.01% | 350 |
|
|
2025
Q2 | $2.75M | Sell |
6,173
-7,151
| -54% | -$3.3M | 0.01% | 294 |
|
|
2025
Q1 | $6.46M | Buy |
13,324
+8,062
| +153% | +$3.76M | 0.04% | 199 |
|
|
2024
Q4 | $2.12M | Sell |
5,262
-12,773
| -71% | -$5.92M | 0.01% | 326 |
|
|
2024
Q3 | $8.39M | Sell |
18,035
-42,168
| -70% | -$20.3M | 0.04% | 198 |
|
|
2024
Q2 | $28.2M | Buy |
60,203
+875
| +1% | +$380K | 0.14% | 104 |
|
|
2024
Q1 | $24.8M | Sell |
59,328
-154,179
| -72% | -$65.2M | 0.12% | 132 |
|
|
2023
Q4 | $86.9M | Sell |
213,507
-3,646
| -2% | -$1.35M | 0.47% | 53 |
|
|
2023
Q3 | $75.5M | Buy |
217,153
+14,476
| +7% | +$5.06M | 0.43% | 61 |
|
|
2023
Q2 | $71.3M | Buy |
202,677
+32,509
| +19% | +$11M | 0.36% | 80 |
|
|
2023
Q1 | $53.6M | Sell |
170,168
-234,697
| -58% | -$70.4M | 0.29% | 108 |
|
|
2022
Q4 | $117M | Sell |
404,865
-122,841
| -23% | -$37.4M | 0.63% | 42 |
|
|
2022
Q3 | $153M | Buy |
527,706
+29,367
| +6% | +$8.45M | 0.77% | 31 |
|
|
2022
Q2 | $140M | Buy |
498,339
+65,885
| +15% | +$17.6M | 0.66% | 36 |
|
|
2022
Q1 | $113M | Buy |
432,454
+42,908
| +11% | +$10.2M | 0.36% | 94 |
|
|
2021
Q4 | $85.5M | Buy |
389,546
+386,859
| +14,397% | +$75.2M | 0.21% | 124 |
|
|
2021
Q3 | $487K | Sell |
2,687
-119
| -4% | -$23.2K | ﹤0.01% | 417 |
|
|
2021
Q2 | $566K | Sell |
2,806
-186,780
| -99% | -$39.1M | ﹤0.01% | 414 |
|
|
2021
Q1 | $40.7M | Sell |
189,586
-374,511
| -66% | -$82.3M | 0.11% | 175 |
|
|
2020
Q4 | $133M | Sell |
564,097
-496,000
| -47% | -$114M | 0.35% | 91 |
|
|
2020
Q3 | $288M | Sell |
1,060,097
-54,485
| -5% | -$15M | 0.84% | 26 |
|
|
2020
Q2 | $324M | Sell |
1,114,582
-525,995
| -32% | -$143M | 1.07% | 19 |
|
|
2020
Q1 | $390M | Buy |
1,640,577
+21,934
| +1% | +$5.03M | 1.72% | 14 |
|
|
2019
Q4 | $354M | Buy |
1,618,643
+185,055
| +13% | +$37.5M | 1.3% | 14 |
|
|
2019
Q3 | $243M | Buy |
1,433,588
+99,046
| +7% | +$17.5M | 0.95% | 23 |
|
|
2019
Q2 | $245M | Sell |
1,334,542
-34,213
| -2% | -$5.98M | 0.94% | 21 |
|
|
2019
Q1 | $252M | Sell |
1,368,755
-621,959
| -31% | -$115M | 1% | 21 |
|
|
2018
Q4 | $330M | Buy |
1,990,714
+4,013
| +0.2% | +$695K | 1.52% | 13 |
|
|
2018
Q3 | $383M | Buy |
1,986,701
+26,208
| +1% | +$4.67M | 1.44% | 14 |
|
|
2018
Q2 | $333M | Buy |
1,960,493
+191,072
| +11% | +$29.6M | 1.4% | 17 |
|
|
2018
Q1 | $288M | Sell |
1,769,421
-249,477
| -12% | -$40.7M | 1.34% | 14 |
|
|
2017
Q4 | $303M | Buy |
2,018,898
+293,215
| +17% | +$43.4M | 1.37% | 14 |
|
|
2017
Q3 | $262M | Buy |
1,725,683
+101,203
| +6% | +$15.2M | 1.23% | 17 |
|
|
2017
Q2 | $209M | Buy |
1,624,480
+414,501
| +34% | +$49.9M | 1% | 24 |
|
|
2017
Q1 | $132M | Sell |
1,209,979
-153,622
| -11% | -$13.5M | 0.66% | 40 |
|
|
2016
Q4 | $100M | Sell |
1,363,601
-246,296
| -15% | -$20M | 0.55% | 44 |
|
|
2016
Q3 | $140M | Buy |
1,609,897
+6,793
| +0.4% | +$642K | 0.72% | 36 |
|
|
2016
Q2 | $138M | Sell |
1,603,104
-365,385
| -19% | -$31.6M | 0.73% | 32 |
|
|
2016
Q1 | $156M | Sell |
1,968,489
-313,802
| -14% | -$28.4M | 0.79% | 28 |
|
|
2015
Q4 | $287M | Sell |
2,282,291
-157,576
| -6% | -$19M | 1.4% | 14 |
|
|
2015
Q3 | $254M | Buy |
2,439,867
+1,640,824
| +205% | +$211M | 1.39% | 11 |
|
|
2015
Q2 | $98.7M | Buy |
799,043
+490,474
| +159% | +$61.8M | 0.44% | 69 |
|
|
2015
Q1 | $36.4M | Buy |
308,569
+82,086
| +36% | +$9.84M | 0.16% | 123 |
|
|
2014
Q4 | $26.9M | Sell |
226,483
-138,698
| -38% | -$15.6M | 0.13% | 135 |
|
|
2014
Q3 | $41M | Sell |
365,181
-8,203
| -2% | -$781K | 0.2% | 104 |
|
|
2014
Q2 | $35.4M | Sell |
373,384
-368,701
| -50% | -$25.9M | 0.17% | 121 |
|
|
2014
Q1 | $52.5M | Buy |
742,085
+139,608
| +23% | +$11.1M | 0.26% | 102 |
|
|
2013
Q4 | $44.8M | Sell |
602,477
-113,038
| -16% | -$7.87M | 0.23% | 110 |
|
|
2013
Q3 | $54.3M | Sell |
715,515
-428,408
| -37% | -$34.1M | 0.3% | 100 |
|
|
2013
Q2 | $91.6M | Buy |
+1,143,923
| New | +$84.2M | 0.54% | 57 |
|
Other funds holding VRTX
VCM
VPM
Fred Alger Management's VRTX Position: Q1 2026 in Review
Fred Alger Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 2,433 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #351.
Fred Alger Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $390M in Q1 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Fred Alger Management held 2,433 shares of Vertex Pharmaceuticals worth $1.09M as of Q1 2026.
- Fred Alger Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #351 holding.
- Fred Alger Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fred Alger Management's Vertex Pharmaceuticals position peaked at $390M in Q1 2020.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.